InspireMD, Inc. financial data

Symbol
NSPR on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
4 Menorat Hamaor St., Tel Aviv, Israel
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Saguaro Resources, Inc. (to 4/1/2011)
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 804 % +29.5%
Quick Ratio 37.8 % +7.3%
Debt-to-equity 18.7 % -30.6%
Return On Equity -62 % +17.5%
Return On Assets -52.3 % +11.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.7M shares +21.3%
Common Stock, Shares, Outstanding 25.2M shares +18.9%
Entity Public Float 46.1M USD +195%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 35.9M shares +70.2%
Weighted Average Number of Shares Outstanding, Diluted 35.9M shares +70.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.57M USD +22.9%
Research and Development Expense 10.2M USD +28.6%
Selling and Marketing Expense 4.87M USD +34.7%
General and Administrative Expense 13.6M USD +49.2%
Operating Income (Loss) -27.1M USD -40.9%
Nonoperating Income (Expense) 1.66M USD +195%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -18.5M USD -24.1%
Net Income (Loss) Attributable to Parent -25.5M USD -36.4%
Earnings Per Share, Basic -0.48 USD/shares +75.5%
Earnings Per Share, Diluted -0.48 USD/shares +8.33%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28.4M USD +146%
Marketable Securities, Current 18.8M USD -34.8%
Accounts Receivable, after Allowance for Credit Loss, Current 1.31M USD -11.1%
Inventory, Net 2.21M USD +30.6%
Assets, Current 51.8M USD +2.62%
Property, Plant and Equipment, Net 1.6M USD +82.7%
Operating Lease, Right-of-Use Asset 1.26M USD -9.44%
Assets 55.7M USD +3.77%
Accrued Liabilities, Current 1.15M USD +54.9%
Liabilities, Current 6.97M USD +44.2%
Operating Lease, Liability, Noncurrent 786K USD -19%
Liabilities 8.9M USD +30.3%
Retained Earnings (Accumulated Deficit) -236M USD -12.1%
Stockholders' Equity Attributable to Parent 46.8M USD -0.11%
Liabilities and Equity 55.7M USD +3.77%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.06M USD -4.82%
Net Cash Provided by (Used in) Investing Activities 4.82M USD +8.27%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 25.2M shares +18.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -251K USD +37.9%
Deferred Tax Assets, Valuation Allowance 42.7M USD +6.44%
Deferred Tax Assets, Gross 42.7M USD +6.44%
Operating Lease, Liability 1.6M USD -1.18%
Depreciation 69K USD +25.5%
Payments to Acquire Property, Plant, and Equipment 195K USD +680%
Lessee, Operating Lease, Liability, to be Paid 1.82M USD -3.86%
Property, Plant and Equipment, Gross 3.1M USD +9.74%
Operating Lease, Liability, Current 557K USD +32.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 584K USD +23.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 579K USD +34%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +11.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 221K USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 653K USD +38.3%
Deferred Tax Assets, Operating Loss Carryforwards 37.3M USD +5.17%
Unrecognized Tax Benefits 168K USD +58.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 513K USD
Additional Paid in Capital 283M USD +9.88%